Tipp

The nasal microbiome in granulomatosis with polyangiitis

Zeitschrift:: Wiener klinisches Magazin > Ausgabe 3/2016

Autor:: M.D. Andreas Kronbichler

» Zum Volltext PDF-Version jetzt herunterladen

Without Abstract

Millet A, Pederzoli-Ribeil M, Guillevin L, Witko-Sarsat V, Mouthon L (2013) Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group? Ann Rheum Dis 72(8):1273–1279. doi:10.1136/annrheumdis-2013-203255 CrossRefPubMed

Kronbichler A, Kerschbaum J, Mayer G (2015) The influence and role of microbial factors in autoimmune kidney diseases: a systematic review. J Immunol Res 2015:858027 doi:10.1155/2015/858027 CrossRefPubMedPubMedCentral

Edwards AM, Massey RC, Clarke SR (2012) Molecular mechanisms of staphylococcus aureus nasopharyngeal colonization. Mol Oral Microbiol 27(1):1–10. doi:10.1111/j.2041-1014.2011.00628.x CrossRefPubMed

Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, Jong PE de, Kallenberg CG (1994) Association of chronic nasal carriage of staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120(1):12–17 CrossRefPubMed

Stegeman CA, Tervaert JW, Jong PE de, Kallenberg CG (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch co-trimoxazole Wegener study group. N Engl J Med 335(1):16–20. doi:10.1056/NEJM199607043350103 CrossRefPubMed

Laudien M, Gadola SD, Podschun R, Hedderich J, Paulsen J, Reinhold-Keller E, Csernok E, Ambrosch P, Hellmich B, Moosig F, Gross WL, Sahly H, Lamprecht P (2010) Nasal carriage of staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps. Clin Exp Rheumatol 28(57):51–55 PubMed

Popa ER, Stegeman CA, Abdulahad WH, Meer B van der, Arends J, Manson WM, Bos NA, Kallenberg CG, Tervaert JW (2007) Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener’s granulomatosis. Rheumatology 46(6):1029–1033. doi:10.1093/rheumatology/kem022 CrossRefPubMed

Kronbichler A, Jayne DR (2015) Con: Should all patients with anti-neutrophil cytoplasmic antibody-associated vasculitis be primarily treated with rituximab? Nephrol Dial Transplant 30(7):1075–1081. doi:10.1093/ndt/gfv216 CrossRefPubMed

Kronbichler A, Jayne DR, Mayer G (2015) Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest 45(3):346–368. doi:10.1111/eci.12410 CrossRefPubMed

10.

Besada E, Koldingsnes W, Nossent JC (2015) Staphylococcus aureus carriage and long-term rituximab treatment for granulomatosis with polyangiitis. PeerJ 3:e1051 doi:10.7717/peerj CrossRefPubMedPubMedCentral

11.

Wohlers J, Breucker K, Podschun R, Hedderich J, Lamprecht P, Ambrosch P, Laudien M (2012) Aberrant cytokine pattern of the nasal mucosa in granulomatosis with polyangiitis. Arthritis Res Ther 14(5):R203 doi:10.1186/ar4041 CrossRefPubMedPubMedCentral

12.

Hui Y, Wohlers J, Podschun R, Hedderich J, Lamprecht P, Ambrosch P, Laudien M (2011) Antimicrobial peptides in nasal secretion and mucosa with respect to s. aureus colonisation in Wegener s granulomatosis. Clin Exp Rheumatol 29(1 Suppl 64):49–56

13.

Laudien M, Hasler R, Wohlers J, Bock J, Lipinski S, Bremer L, Podschun R, Ambrosch P, Lamprecht P, Rosenstiel P, Till A (2011) Molecular signatures of a disturbed nasal barrier function in the primary tissue of Wegener’s granulomatosis. Mucosal Immunol 4(5):564–573. doi:10.1038/mi.2011.9 CrossRefPubMed

14.

Ullrich S, Gustke H, Lamprecht P, Gross WL, Schumacher U, Ambrosch P, Laudien M (2009) Severe impaired respiratory ciliary function in Wegener granulomatosis. Ann Rheum Dis 68(6):1067–1071. doi:10.1136/ard.2008.096974 CrossRefPubMed

15.

Glasner C, Timmeren MM van, Stobernack T, Omansen TF, Raangs EC, Rossen JW, Goffau MC de, Arends JP, Kampinga GA, Koedijk DG, Neef J, Buist G, Tavakol M, Wamel WJ van, Rutgers A, Stegeman CA, Kallenberg CG, Heeringa P, Dijl JM van (2015) Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term staphylococcus aureus exposure. Sci Rep 5:8188 doi:10.1038/srep08188 CrossRefPubMed

Titel: The nasal microbiome in granulomatosis with polyangiitis
Autor:: M.D. Andreas Kronbichler
Publikationsdatum: 01.06.2016
DOI: https://doi.org/10.1007/s00740-016-0116-3
Verlag: Springer Vienna
Zeitschrift: Wiener klinisches Magazin
Ausgabe 3/2016
Print ISSN: 1869-1757
Elektronische ISSN: 1613-7817

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Without Abstract

Weitere Artikel der Ausgabe 3/2016

Strahlentherapie als Alternative zur Radikaloperation. Blasenkrebs schonender behandeln

Panorama

Diagnostik bei renaler Osteodystrophie

PBC nicht übersehen

Chemotherapie und/oder Immuntherapie?

53. Kongress der Europäischen Nephrologischen Gesellschaft